P075 Feasibility of 12 weeks melatonin supplementation in Mild Cognitive Impairment

INTRODUCTION: Melatonin has been hypothesised to slow cognitive decline in older adults due to its proposed multiple therapeutic benefits. METHODS: Participants with Mild Cognitive Impairment (MCI) were recruited from the community for a pilot 12-week randomised placebo-controlled trial of 25mg oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Menczel Schrire, Z, Phillips, C, Duffy, S, Marshall, N, Mowszowski, L, LaMonica, H, Gordon, C, Naismith, S, Grunstein, R, Hoyos, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109307/
http://dx.doi.org/10.1093/sleepadvances/zpac029.145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109307/
http://dx.doi.org/10.1093/sleepadvances/zpac029.145

Ejemplares similares